News

The gastrointestinal tract holds a vast community of diverse microbes, and many of them play crucial roles in our health. | ...
A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...
A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...
Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.
Breeze Hunter, 22, a student at Texas A&M University has revealed how a headache and pressure in her nose led her shock diagnosis.
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...
Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...
A woman in England ran her 13th marathon in a year to raise money for a cancer charity — and she crossed the finish line in ...
A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.
The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...